SAN DIEGO–(BUSINESS WIRE)–#BoothDesign–Inc., the only prominent brand focused solely on supporting owners and leaders of growing private businesses, has ranked Exponents as no. 1087 on the 2025 Inc. 5000 list. The recognition reflects Exponents’ 3x revenue growth over the past three years and marks a major milestone for the privately held booth design and build […]

PARIS–(BUSINESS WIRE)–Regulatory News: The Shareholders’ Meeting of Rémy Cointreau (Paris:RCO), held on July 22, 2025 in Paris, has approved the payment of an ordinary dividend of €1.50 per share, related to the 2024-25 fiscal year, €1.0 in cash, and €0.5 with an option for payment in cash or in shares. The option period was open […]

Second positive phase 3 trial of Daiichi Sankyo and AstraZeneca’s ENHERTU in HER2 positive early breast cancer reinforces its potential to become a foundational treatment option in curative-intent setting Results from the DESTINY-Breast05 and DESTINY-Breast11 trials will be presented at ESMO 2025 in a Presidential Symposium Plans for regulatory submissions are underway TOKYO & BASKING […]

Corpay’s business and financial institutional clients will benefit from near-real-time payouts to 22 new markets, leveraging Mastercard Move’s extensive network. FRANKFURT, Germany–(BUSINESS WIRE)–Corpay and Mastercard announce today an expansion of their long-standing collaboration to enable corporates, small businesses and financial institutions to make near real-time payments to 22 new markets across Asia, Europe, the Middle […]

Corporate CFOs and Treasurers harness AI, cards and digital tools to navigate growth and volatility SAN FRANCISCO–(BUSINESS WIRE)–Visa (NYSE:V), a global leader in digital payments, today released findings from its third annual Growth Corporates Working Capital Index, based on insights from more than 1,400 CFOs and Treasurers across 10 industries and 23 countries. The data […]

LYON, France–(BUSINESS WIRE)–Regulatory News: POXEL SA (Euronext: POXEL – FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including metabolic dysfunction-associated steatohepatitis (MASH) and rare metabolic disorders, today announces the availability of a bond issue for a maximum amount of €2.5 million to finance its observation period. Poxel […]

Company Announcement Genmab to acquire Merus for USD 97.00 per share in an all-cash transaction representing a transaction value of approximately USD 8.0 billion Proposed acquisition adds petosemtamab, a late-stage asset with two Breakthrough Therapy Designations, to Genmab’s portfolio Transaction anticipated to be accretive to EBITDA by end of 2029 Genmab to host a conference […]

Find exceptional seasonal savings across top categories including up to 50% off select fashion from Levi’s and CIDER; up to 45% off select home products from BISSELL and iRobot; and up to 40% off select toys from American Girl, Play-Doh, and Tonies Shop deals on new-to-Amazon brands like Vans, Milk Makeup, and Drunk Elephant; save […]

SCHLIEREN, Switzerland–(BUSINESS WIRE)–Virometix AG, a Swiss clinical-stage biotechnology company pioneering fully synthetic vaccines, today announced that it has successfully completed enrollment in the Phase I clinical trial of V-212, a peptide-based, serotype-independent vaccine candidate targeting Streptococcus pneumoniae infections. “Completing enrollment in this Phase I trial marks a significant milestone for V-212,” said Anna Sumeray, CEO […]

LONDON–(BUSINESS WIRE)–Maple Finance, one of the largest onchain asset managers, and Elwood Technologies, a leading institutional platform for digital asset trading, portfolio and risk management, today announced a strategic partnership to help support the growing demand from institutions accessing digital asset credit strategies. Under the partnership, Elwood will provide Maple with connectivity, execution, portfolio management […]